AbClon Competitors and Similar CompaniesClear all

AbClon's competitors and similar companies include Creative Bio-Peptides, Kinnov Therapeutics, Upstream Bio and Albert Labs.
AbClon
AbClon
AbClon (앱클론(주)) is a developer, manufacturer, and distributor of antibody drugs.
Creative Bio-Peptides
Creative Bio-Peptides
Creative Bio-Peptides (CBP) is a company that develops disease-modifying oral chemokine antagonist peptides that repair and regenerate damaged neurons.
Kinnov Therapeutics
Kinnov Therapeutics
Kinnov Therapeutics is a company dedicated to the research and development of therapies against addiction.
Upstream Bio
Upstream Bio
Upstream Bio is a clinical-stage biotechnology company that develops treatments for inflammatory diseases.
Albert Labs
Albert Labs
Albert Labs is a clinical research and drug development company.
Founding Date
Founding Date
2010
Founding Date
2017
Founding Date
N/A
Founding Date
2021
Founding Date
2009
Type
Type
Public
Type
Private
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
KR HQ
Locations
Rockville, US HQ
Locations
Orléans, FR HQ
Locations
Waltham, US HQ
Locations
Burnaby, CA HQ
Porto, PT
Manchester, GB
Employees
Employees
N/A
Employees
4
Employees
N/A
Employees
38
Employees
N/A
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
1.3 b
Valuation ($)
401.7 k

Financial

Revenue (est.)
Revenue (est.)
₩2.3b (FY, 2024)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$2.9m (FY, 2025)
Revenue (est.)
N/A
Cost of goods
Cost of goods
(₩74.1m) (FY, 2024)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$23m (FY, 2025)
Cost of goods
N/A
Gross profit
Gross profit
₩2.4b (FY, 2024)
Gross profit
N/A
Gross profit
N/A
Gross profit
($20.2m) (FY, 2025)
Gross profit
N/A
Net income
Net income
(₩16.3b) (FY, 2024)
Net income
N/A
Net income
N/A
Net income
($143.4m) (FY, 2025)
Net income
($7.1m) (FY, 2022)
For sources of this data, please see the company profile

View Company Profiles

Creative Bio-Peptides
HQ
Rockville, US
Employees
4

Creative Bio-Peptides (CBP) is a company that develops disease-modifying oral chemokine antagonist peptides that repair and regenerate damaged neurons.

View company
Kinnov Therapeutics
HQ
Orléans, FR

Kinnov Therapeutics is a company dedicated to the research and development of therapies against addiction.

View company
Upstream Bio
HQ
Waltham, US
Employees
38

Upstream Bio is a clinical-stage biotechnology company that develops treatments for inflammatory diseases.

View company
Albert Labs
HQ
Burnaby, CA

Albert Labs is a clinical research and drug development company.

View company